Andreas Fretzayas
Overview
Explore the profile of Andreas Fretzayas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tzifi F, Fretzayas A, Chrousos G, Kanaka-Gantenbein C
Hormones (Athens)
. 2019 May;
18(3):255-265.
PMID: 31140156
Non-alcoholic fatty liver disease (NAFLD) constitutes the most common liver disease, one that is still underdiagnosed in pediatric populations (as well as in the general population), this due to the...
2.
Sideri V, Antonakos G, Fretzayas A, Attilakos A, Chrelias C, Papaevangelou V, et al.
Endocr Metab Immune Disord Drug Targets
. 2018 Jul;
19(2):159-165.
PMID: 30033883
Background/objectives: The aim of this work was to evaluate the current vitamin D status in healthy pregnant women and their newborns living in Greece and assess possible associations between 25(OH)D...
3.
Fretzayas A, Gole E, Attilakos A, Daskalaki A, Nicolaidou P, Papadopoulou A
Pediatr Int
. 2013 Jun;
55(3):371-3.
PMID: 23782368
Bartter syndrome (BS) is a group of genetic disorders characterized by hypokalemic metabolic alkalosis, hyponatremia and elevated renin and aldosterone plasma concentrations. BS type II is caused by mutations in...
4.
Papadimitriou D, Marakaki C, Fretzayas A, Nicolaidou P, Papadimitriou A
J Diabetes
. 2013 Jan;
5(3):344-8.
PMID: 23302101
Background: Based on recent knowledge of the possible involvement of 1,25-dihydroxyvitamin D in the pathogenesis of type 1 diabetes (T1D) and the results of its administration in animal models, we...
5.
Papadimitriou A, Douros K, Papadimitriou D, Kleanthous K, Karapanou O, Fretzayas A
J Paediatr Child Health
. 2011 Nov;
48(3):263-7.
PMID: 22112203
Aim: To describe the characteristics of short children in relation to gender and the various diagnoses. Methods: All new patients of Greek origin that were referred to our institution in...
6.
Papadimitriou A, Douros K, Kleanthous K, Papadimitriou D, Attilakos A, Fretzayas A
J Adolesc Health
. 2011 Sep;
49(4):434-6.
PMID: 21939877
Purpose: To examine pubertal status of contemporary Greek boys and compare the data with those of a previous study we performed in the year 1996. Methods: We performed a cross-sectional...
7.
Papadimitriou A, Kanakis G, Douros K, Papadimitriou D, Boutsiadis A, Nicolaidou P, et al.
Horm Res Paediatr
. 2011 Aug;
76(4):273-7.
PMID: 21860223
Background: Constitutional advancement of growth (CAG) is the growth pattern of early growth acceleration that has been shown to be characteristic in girls with idiopathic precocious puberty (IPP). The aim...
8.
Dinopoulos A, Karapanou O, Alexopoulou E, Tzetis M, Attilakos A, Fretzayas A
Eur J Paediatr Neurol
. 2011 Jul;
15(5):453-5.
PMID: 21778093
A 4.5 years old male with myoclonic epilepsy on Valproic acid (VPA) monotherapy, developed an acute pancreatitis. The discontinuation of VPA and substitution with Levetiracetam was followed by clinical improvement...
9.
Papadopoulou A, Issakidis M, Gole E, Kosma K, Fryssira H, Fretzayas A, et al.
Eur J Pediatr
. 2011 May;
171(1):51-8.
PMID: 21590266
Noonan syndrome (NS) is a common multiple congenital anomaly entity, the diagnosis of which, on clinical grounds, is based on a comprehensive scoring system in order to select patients for...
10.
Papadimitriou A, Nicolaidou P, Fretzayas A, Chrousos G
J Clin Endocrinol Metab
. 2010 Jul;
95(10):4535-41.
PMID: 20610589
Context: Constitutional advancement of growth (CAG), a.k.a. early growth acceleration, refers to a growth pattern that is characterized by growth acceleration soon after birth, reaching a zenith centile in the...